Tuberous sclerosis is an autosomal dominant disorder. Besides the development of benign growths (hamartomas) in dierent tissues, one hallmark of this disease is the presence of highly epileptogenic dysplastic lesions in the cerebral cortex (tubers) composed of abnormal shaped neurones. Patients often show evidence of severe mental retardation. Linkage analysis revealed two diseasedetermining genes on chromosome 9 and chromosome 16. The TSC2 gene on chromosome 16 encodes a 1784-amino acid putative tumour suppressor protein, tuberin, that functions as a GTPase-activating protein. Here we show that tuberin expression is upregulated upon induction of neuronal dierentiation in the neuroblastoma cell lines SK-N-SH and LAN-1. This upregulation occurs at post-transcriptional level and is independent of the proliferation status. TSC2 expression is unaected during dierentiation of C2C12 myoblasts into myotubes and of F9 embryonal carcinoma cells into cells resembling parietal endoderm. Antisense inhibition of tuberin expression in SK-N-SH or LAN-1 cells inhibits neuronal dierentiation, but does not aect the dierentiation of F9 cells. Ectopic overexpression of TSC2 not only reverts the antisense-associated phenotype but furthermore accelerates the neuronal dierentiation process. Our data show for the ®rst time that tuberin plays a critical role in neuronal dierentiation. Such role is consistent with the phenotype of tuberous sclerosis patients, who inherit one defective TSC2 allele, and frequently lose the remaining normal allele in many of the tubers/hamartomas which develop in the central nervous system of these patients.
Introduction
Tuberous sclerosis (TSC) is an autosomal dominant condition with an estimated prevalence of about 1 in 10 000 (Wiederholt et al., 1985) . This disease is characterized by mental retardation, epilepsy, and tumours of the skin, retina, heart, kidney, and brain (Gomez, 1988; Osborn et al., 1991) . Tubers are regions of focal cerebral cortical dysplasia, which exhibit disorganized or absent cortical lamination and dysmorphic neurons with abnormal dendritic arborization and spine density. Many of these abnormally shaped neurons are stellate or multipolar cells not characteristic of normal cortex (Huttenlocher and Wollman, 1991) . Clinically, tubers are frequently identi®ed as epileptogenic foci, which require surgical excision in patients with TSC and refractory epilepsy (Gomez, 1988) . The molecular events that lead to the genesis of these abnormal neurones during cortical development are unknown.
Linkage studies in families with TSC show that about 50% are associated with a mutant TSC2 gene, located on chromosome 16, while TSC1, which maps to chromosome 9 is implicated in the remainder (Sampson et al., 1992; Kwiatkowski et al., 1993; The European Chromosome 16 Consortium, 1993; Povey et al., 1994; Janssen et al., 1994; Sampson and Harris, 1994; The TSC1 Consortium, 1997) . Mutations in the TSC2 gene have been described in patients with TSC (Kumar et al., 1995; Wilson et al., 1996) and loss of heterozygosity at the TSC2 locus has been demonstrated in TSC patient lesions, as well as in sporadic tumours of non-TSC patients (Green et al., 1994; Henske et al., 1995; Carbonara et al., 1996) . The TSC2-encoded protein, designated tuberin, functions as a GTPase accelerating protein (GAP) for the small molecular weight GTPases Rap1a and Rab5 (Wienecke et al., 1995 Xiao et al., 1997) . Very recently, we have shown that the absence of tuberin can induce quiescent Go-arrested cells to re-enter the cell cycle. Loss of TSC2 can prevent cells from entering a quiescent state after serum withdrawal and can induce cells to pass through the G1/S transition of the eukaryotic cell cycle. Re-entry into the cell cycle upon loss of TSC2 is accompanied by upregulation of cyclic D1 and is dependent on the activity of the G1-cyclin-dependent kinases, CDK2 or CDK4 (Soucek et al., 1997b) .
The Eker rat strain has provided an animal model system for the analysis of TSC2. The Eker mutation is a germline insertion in the rat homologue of the human TSC2 gene, resulting in premature truncation of TSC2 (Yeung et al., 1994; Kobayashi et al., 1995; Xiao et al., 1995) . Heterozygous carriers are characterized by the onset of renal tumours, sometimes associated with other neoplasia and the susceptibility of these rats to carcinogens is increased (Walker et al., 1992; Hino et al., 1993) . Fetuses homozygous for the Eker TSC2 mutation die in midgestation with apparent abnormalities in central nervous system development (Hino et al., 1993) . Recently, direct evidence for the tumour suppressor function of TSC2 was obtained by introduction of the TSC2 cDNA into cell lines derived from Eker rat tumours. Overexpression of TSC2 inhibited the growth and suppressed the tumourigenicity of these lines (Jin et al., 1996; Orimoto et al., 1996) .
In this study we investigated the role of TSC2 in the regulation of neuronal dierentiation. We found a post-transcriptional upregulation of tuberin during neuronal dierentiation in SK-N-SH cells and LAN-1 cells, which was independent of the proliferation status of the cell. Induction of myocyte dierentiation in C2C12 cells and dierentiation of F9 cells into cells resembling parietal endoderm did not aect tuberin expression. To examine the biological role of these observations we altered intracellular tuberin expression by downregulation upon antisense treatment as well as by upregulation via ectopic overexpression. Antisense treatment inhibited neuronal dierentiation in SK-N-SH and LAN-1 cells. This eect could be reverted by ectopic overexpression of TSC2 in antisense-treated cells. Furthermore, overexpression of TSC2 accelerated neuronal dierentiation in these cells. Our data provide strong evidence that tuberin plays an essential role during neuronal dierentiation. These ®ndings open the door to a better understanding of the development of the lesions found in the brain of TSC patients.
Results
We induced neuronal dierentiation in the neuroblastoma cell lines SK-N-SH and LAN-1 by adding retinoic acid (RA) into the culture medium. During this dierentiation these cells withdraw permanently from the cell cycle (Thiele et al., 1985 (Thiele et al., , 1988 Abemayor and Sidell, 1989) . We followed this eect bȳ owcytometric analysis of S-phase content (Figures 1  and 2 ). These data were con®rmed by analysis of thymidine incorporation into DNA (data not shown). As markers for the proper induction of neuronal dierentiation in these cells we investigated the expression of the proto-oncogene RET as well as the expression of the cyclin-dependent kinase inhibitor p27, which have earlier been shown to be induced during this process (Tahira et al., 1991; Kranenburg et al., 1995; Figures 1 ± 3) . On the cellular level the dierentiation can easily be detected by a shift in cell morphology. Relatively small cells with rounded appearance become¯attened, enlarged, and extensive outgrowth of neurites is observed upon RA treatment (Figures 3 ± 5) . Analysing extracts prepared at dierent time points of RA treatment revealed a remarkable induction of tuberin protein expression within the ®rst 24 h (Figures 1 and 2 ). TSC2 mRNA expression was already high in undierentiated neuroblastoma cells and was not aected by RA (Figures 1 and 2) . A more detailed time course analysis revealed that tuberin is upregulated within the ®rst 6 h of neuronal differentiation, parallel to an induction of the expression of RET and before an induction of p27 (Figure 3a ). This upregulation of protein expression could also be detected by immunocytochemical investigation of tuberin expression in dierentiating SK-N-SH cells (Figures 3b and 5 to a more uniform staining upon dierentiation (Figures 3b and 5 ). To investigate whether tuberin expression is upregulated in these experiments because of dierentiation or because of cell cycle arrest we induced neuronal dierentiation of SK-N-SH cells with dimethylsulphoxide (DMSO). Under the conditions of these experiments SK-N-SH cells underwent neuronal dierentiation, as detected by neurite outgrowth (data not shown) and RET expression (Figure 1 ), before withdrawal from the cell cycle ( Figure 1 ). However, we observed a similar, although much later, post-transcriptional upregulation of tuberin expression, which was clearly independent of any eects on the cell cycle ( Figure 1 ). Dierentiation of F9 embryonal carcinoma cells into cells resembling parietal endoderm can be eected by adding RA into the medium. This dierentiation is accompanied by cell cycle arrest (Strickland & Mahdavi, 1978) . Dierentiation of C2C12 myoblasts is induced when cultures are shifted to medium containing low concentrations of mitogens. During this process myoblasts withdraw from the cell cycle, express muscle-speci®c structure proteins, and fuse into TSC2 in neuronal differentiation T Soucek et al multinucleated myotubes (Nadal-Ginard, 1978) . Immunoblot analyses revealed that both types of dierentiation have no eect on tuberin expression (Figure 6 ). To address the requirement for tuberin expression during neuronal dierentiation we employed antisense oligonucleotides to block the expression of tuberin. We used an antisense phosphorothioate oligonucleotide (PTO) directed against the GAP3 region of the TSC2 gene. As a mismatch control we used an oligonucleotide of the same length with the same proportion of the four basepairs, but randomly organized. Treatment of SK-N-SH cells with the antisense oligonucleotide resulted in a dramatic reduction of the level of tuberin, whereas the mismatch control had no eects on the intracellular level of tuberin. This reduction upon antisense treatment was detected by immunocytochemical investigation of intracellular tuberin expression ( Figure 5 To demonstrate the speci®city of the antisense oligonucleotides, we showed that enforced ectopic expression of tuberin in antisense-treated cells restored the ability of SK-N-SH cells to undergo neuronal dierentiation upon RA treatment. Overexpression of TSC2 by transfection of full length cDNA under a constitutive promoter led to high protein levels of tuberin also in TSC2-antisense oligo treated cells (Figure 7a) . A CD20 construct driven by the cytomegalovirus (CMV) early promoter was used to detect transfected cells and to estimate transfection eciency (Figure 7b) . A 12 ± 16% transfection efficiency was usually achieved in cultured SK-N-SH cells. Accordingly, the Western blot shown in Figure 7a represents a protein extract of a mixture of about 15% tuberin-overexpressing cells and of about 85% untransfected cells. The observed high level of tuberin expression allows the conclusion that the transfected cells express extensively higher intracellular levels of tuberin than untransfected counterparts. (Figure 7b ). Moreover, neuronal dierentiation upon RA treatment of SK-N-SH cells expressing high levels of tuberin because of ectopic overexpression was accelerated. After 12 h RA treatment about 45% and after 24 h about 75% transfected SK-N-SH cells exhibited long neurites, whereas only about 30% and 60% of untransfected counterparts had long neurites at the respective time points (Figure 8a ). Cells co-transfected with the empty vector and the CD20 construct behaved identical to untransfected cells (Figure 7b and data not shown).
Our data allow the conclusion that tuberin is necessary for RA-induced neuronal dierentiation of SK-N-SH cells. Furthermore, high levels of this protein accelerate dierentiation upon RA treatment. These data have important implications in understanding the development of tubers/hamartomas in the central nervous system of tuberous sclerosis patients. However, we further known that high levels of tuberin are not sucient to induce neuronal dierentiation in SK-N-SH cells in the absence of RA. Ectopic overexpression of tuberin alone did not lead to an increase in cells with neurites longer than 100 mm (data not shown).
Discussion
Tuberous sclerosis (TSC) is characterized by the development of benign growths termed hamartomas, mainly involving eyes, skin and central nervous system (Gomez, 1988) . Given the high incidence of central nervous system abnormalities in individuals aected with TSC, it is tempting to speculate that the tuberous sclerosis-2 gene product, tuberin, might have important functions relevant to neuronal dierentiation and development. Dierent investigators reported high levels of tuberin expression in normal human brain tissues (Geist and Gutmann, 1995; Menchine et al., 1996; Kerfoot et al., 1996; Wienecke et al., 1997) . We found tuberin expression to be highly upregulated during neuronal dierentiation in SK-N-SH cells and LAN-1 cells, but to be unaected during dierentiation of F9 cells into cells resembling parietal endoderm and during myocyte dierentiation of C2C12 cells. The latter might re¯ect why hamartomas in skeletal muscle of TSC patients have not been described (Sampson and Harris, 1994) . We further found the upregulation of tuberin expression during neuronal dierentiation to be independent from any eect on the cell cycle. We have earlier shown that tuberin expression is not aected when cells exit the cell cycle to enter the quiescent G O state (Soucek et al., 1997b) , what furthermore proofs that the elevated tuberin expression results from the induction of the process of neuronal dierentiation. The fact that we found this upregulation to occur at a posttranscriptional level is also in agreement with earlier reported discrepancies between TSC2 mRNA expression and protein levels in dierent compartments of human brain (Kerfoot et al., 1996) . In addition, we have recently provided evidence that the cell cycle function(s) of tuberin may be regulated at post-transcriptional levels (Soucek et al., 1997b) . Analysing cryosections and paran sections of a panel of normal human organs Wienecke and colleagues recently reported two intracellular patterns of tuberin localization. In the majority of cells, tuberin was seen in a perinuclear and punctate pattern consistent with the earlier reported Golgi localization of tuberin . However, tuberin staining was predominantly cytoplasmic in neuronal cells and in cells involved in secretory functions (Wienecke et al., 1997) . In agreement with these ®ndings, tuberin localization appeared to shift from a perinuclear to a more uniform staining during neuronal dierentiation of SK-N-SH cells.
Here we report, using antisense oligonucleotides, that loss of tuberin expression blocks neuronal In parallel the cells were treated with 15 mM TSC2 antisenseoligonucleotide (AS) or with the mismatch control oligonucleotide (MSM). Dierentiation was investigated by microscopic detection of the dierentiated cell morphology. More than 100 cells were examined in each analysis TSC2 in neuronal differentiation T Soucek et al dierentiation in SK-N-SH and LAN-1 cells upon treatment with retinoic acid or DMSO. Dierentiation of F9 into cells resembling parietal endoderm was not aected by treatment with TSC2 oligonucleotides. These data are, to our knowledge, the ®rst to demonstrate an essential role for tuberin in regulating the process of neuronal dierentiation. Our study touches the important question regarding the clinical manifestation of tuberous sclerosis in the central nervous system of such patients. Our results suggest that neuronal cells lacking functional tuberin, such as the cells which give rise to the lesions of TSC patients, may also fail to dierentiate normally. Such a scenario may underly the development of inappropriate growths (tubers/hamartomas) in the central nervous system, which is the hallmark of TSC. Mutations in the TSC2 gene have been described in patients with TSC (Kumar et al., 1995; Wilson et al., 1996) and loss of heterozygosity at the TSC2 locus has been demonstrated in TSC patient lesions (Green et al., 1994; Henske et al., 1995; Carbonara et al., 1996) . It was recently demonstrated that neurons in cortical tubers of TSC patients express several mRNAs and proteins, which are characteristic of embryonic neuroepithelial precursor cells (Crino et al., 1996) . These ®ndings suggested a fundamental disruption of neuronal dierentiation in tubers, although whether alterations in neuronal maturation resulted directly from a TSC2 mutation remained to be determined. Our data that loss of TSC2 expression is sucient to block neuronal dierentiation make it very likely that tubers in TSC patients may re¯ect disruption of neuronal maturation because of loss of functional tuberin.
We further show that ectopic overexpression of tuberin in SK-N-SH cells accelerates the process of neuronal dierentiation in these cells. Again, these results provide strong evidence for an important role of the TSC2 gene product in the development and dierentiation of nervous system tissues. Such a role is very likely also re¯ected by the earlier reported high levels of tuberin expression in central nervous system neurons (Geist and Gutmann, 1995; Menchine et al, 1996; Kerfoot et al., 1996; Wienecke et al., 1997) . However, whereas our data allow the conclusion that tuberin expression is required for the process of neuronal dierentiation to be completed, we also know that induction of tuberin expression is not sucient to initiate the dierentiation program. Ectopic overexpression of tuberin in SK-N-SH cells, which were not induced to dierentiate by DMSO or RA, does not lead to induction of neuronal dierentiation.
One possible function of tuberin during neuronal dierentiation is suggested by the recent ®nding that it functions as a GTPase activating protein for Rab5 in modulating endocytosis (Xiao et al., 1997) . Small GTPbinding proteins, such as Rab5a, have been shown to be involved in the regulation of neuronal endocytosis (de Hoop et al., 1994) .
Another possible mechanism that may underly the eects of tuberin on neuronal dierentiation was originally suggested by the presence in tuberin of a region of homology to the GTPase accelerating protein (GAP) for the small molecular weight GTPase Rap1 (The European Chromosome 16 Tuberous Sclerosis Consortium. 1993) . It has been shown that tuberin, like Rap1GAP, possesses in vitro GAP activity for Rap1 (Wienecke et al., 1995) . Rap1 is a member of the superfamily of Ras-related proteins, which are active when bound to GTP and inactive when bound to GDP (Lowy and Willumsen, 1993) . Thus, by accelerating the intrinsic GTPase activity of Rap1, tuberin can lead to its inactivation. Therefore, loss of TSC2, as observed in dierent tissues and organs of tuberous sclerosis patients, may lead to the constitutive activation of Rap1. Although its biological role has not been identi®ed, Rap1 has been shown to induce DNA synthesis and morphological changes when microinjected in 3T3 mouse ®broblasts (Yoshida et al., 1992) .
Given that we here show a functional role of tuberin in the process of neuronal dierentiation and that potential molecular targets of tuberin have been identi®ed previously it is now possible and of interest to investigate the molecular mechanism by which tuberin exerts its eect on neuronal dierentiation.
Materials and methods

Cells and tissue culture
All cells were grown either in Dulbecco's modi®cation of Eagle's medium (DMEM) or in RPMI 1640 medium, both supplemented with 10% calf serum and antibiotics (30 mg/l penicillin, 50 mg/l streptomycin sulphate). All cultures were kept at 378C and 7% CO 2 and routinely screened for mycoplasma. The following cell lines were obtained from the American Type Culture Collection (ATCC) and grown according to the protocols of the ATCC: C2C12 mouse muscle myoblasts (ATCC CRL 1772), F9 mouse embryonal carcinoma cells (ATCC CRL 1720) and SK-N-SH human neuroblastoma cell (ATCC HB11). LAN-1 human neuroblastoma cells were established by Dr RC Seeger, Department of Pediatrics, UCLA and grown as described (Seeger et al., 1977) . C2C12 myoblasts were dierentiated into myotubes by changing growth medium to DMEM with 2% horse serum and 1% glucose (NadalGinard, 1978) . F9 dierentiation into cells resembling parietal endoderm was aected by additional of retinoic acid (®nal concentration 0.3 mM) to the medium (Strickland and Mahdavi, 1978) . Neuronal dierentiation of SK-N-SH cells and LAN-1 cells was performed by adding retinoic acid (®nal concentration 20 mM) or DMSO (®nal concentration 1.5%) into the medium (Thiele et al., 1985 (Thiele et al., , 1988 Abemayor and Sidell, 1989; Tahira et al., 1991; Kranenburg et al., 1995) .
Neurite length measurements
The neurites were measured for each neuron. Only the longest neurite per cell was used for comparative purposes with other neurons. Lengths were determined as the distance between the edge of the cell body and the tip of the growth cone. Only clearly visible cells were subjected to analysis to prevent inaccurate scoring and the analyses were carried out`blind' to avoid any subjective in¯uences during the measurements. Transfected neurons were distinguished from untransfected cells by immunodetection of the co-transfected marker protein CD20.
Flow cytometry and [ 3 H]thymidine incorporation
For cyto¯uorometric analyses cells were harvested by trypsinization and ®xed by rapid submersion in 5 ml of ice-cold 85% ethanol. After at least 1 h ®xation at 7208C cells were pelleted and stained in 1 ml staining solution TSC2 in neuronal differentiation T Soucek et al (0.25 mg/ml propidium iodide, 0.05 mg/ml RNAse, 0.1% Triton X-100 in citrate buer (pH 7.8)). Stained cells were analysed on a Becton-Dickinson FACScan. In addition, growth rates were determined by pulse labeling with radiolabeled thymidine. Labeled DNA was precipitated by trichloracetic acid, collected on glass ®bre ®lters and quantitated by scintillation counting (Soucek et al., 1997b) .
Western blot analyses
Protein extracts were prepared in buer containing 20 mM HEPES pH 7.9, 0.4 M NaCl, 2.5% glycerol, 1 mM EDTA, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 0.5 mM NaF, 0.5 mM Na 3 VO 4 , 0.02 mg/ml leupeptin, 0.02 mg/ml aprotinin, 0.003 mg/ml benzamidinchloride, 0.1 mg/ml trypsin inhibitor and 0.5 mM DTT. After 20 min on ice, the extracts were centrifuged and supernatants were stored at 7708C. Protein concentrations were determined using the BioRad protein assay reagent with bovine serum albumine as a standard. A total of 200 mg of protein was run on a 8% SDS-polyacrylamide gel and transferred to nitrocellulose. Blots were stained with Ponceau-S to con®rm equal loaded amounts of protein.
Immunodetection was performed using anti-tuberin antibodies (SC-892 or SC-893, St Cruz, California, USA), anti-RET antibody (SC-167, St Cruz) and anti-p27 antibody (SC-528, St Cruz). Signals were developed using the enhanced chemiluminescence method (Amersham) (Soucek et al., 1997b) .
Northern blot analyses
Northern blot analyses were performed as described previously (Soucek et al., 1997a) . RNA, prepared using TriReagent (Molecular Research Center, Inc.), was denatured in 1 M deionized glyoxal, 4.8% dimethyl sulfoxide and 10 mM sodium phosphate (pH 6.8) for 1 h at 508C. RNA was resolved on a 1.2% agarose gel in 10 mM sodium phosphate (pH 6.8), transferred to nylon in 206SSC and immobilized by U.V. ®xation. Filters were hybridized in 1% BSA, 7% SDS, 0.5 M sodium phosphate buer (pH 6.8) and 1 mM EDTA for at least 10 h at 658C. After successive washing in 0.5% BSA, 5% SDS, 40 mM sodium phosphate (pH 6.8), 1 mM EDTA, and in 1% SDS, 40 mM sodium phosphate (pH 6.8), 1 mM EDTA at 658C ®lters were exposed. Hybridization cDNA probes were speci®c for rat and human TSC2 (Soucek et al., 1997b) .
Antisense treatment
The used oligonucleotides were: AS (antisense), antisense oligonucleotide speci®c for the GAP3 region of the TSC2 gene and MSM (mismatch control), oligonucleotide of the same length with the same proportion of the four basepairs, but randomly organized (for details concerning the oligonucleotides see Soucek et al., 1997b) . The oligonucleotides were purchased from Pharmacia Biotech, Vienna, Austria. We used phosphorothioate oligomers (PTO) to ensure sucient stability against intracellular DNAses. All PTOs were repeatedly ethanol precipitated and were dissolved in double distilled water and quantitated by optical density at OD 260 . The cells were grown as described above and the PTOs were added into freshly changed medium. We routinely used 15 mM oligonucleotides, which induced signi®cant downregulation of tuberin without any eects on the cell viability or morphology. For a detailed description of the used antisense treatment protocol as well as a description of the speci®city, biological stability, intracellular availability and gene suppression potency, toxicity, and nonspeci®c eects of PTOs see (Schlingensiepen and Brysch, 1992; Soucek et al., 1997b) .
DNA transfection and immunocytochemistry
TSC2 cDNA downstream of a constitutive expression promoter and CMV/CD20 were cotransfected into cell culture cells by the calcium-phosphate method as described earlier (Pusch et al., 1997; Soucek et al., 1997b) . For immunocytochemical detection of tuberin cells were ®xed in cold methanol: acetone (1:1) and incubated with tuberin antibody at room temperature for two hours. Thereafter cells were washed with PBS, incubated with biotinylated secondary-antibody, washed again, and incubated with Texas red-conjugated streptavidin (HengstschlaÈ ger et al., 1996) . CD20 positive cells were immunocytochemically detected by staining with a¯uorescein isothiocyanateconjugated anti-CD20 antibody (Becton Dickinson) as described (Pusch et al., 1997) .
